{"filing":{"accession_number":"0001756770-26-000066","cik":"0001756770","ticker":"CURLF","company_name":"Curaleaf Holdings, Inc.","form":"6-K","filing_date":"2026-07-14","report_date":null,"primary_document":"a6-kcover07132026curaleaff.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1756770/000175677026000066/a6-kcover07132026curaleaff.htm"},"events":[{"id":17799,"run_id":15960,"accession_number":"0001756770-26-000066","anchor_item_number":"EX-99.1","event_type":"operational_other","event_domain":"operational","is_material":true,"confidence":0.85,"summary":"Curaleaf announced that Spain's AEMPS has approved registration of two standardized cannabis preparations (THC-dominant and CBD-dominant) developed by its Spanish subsidiary, making Curaleaf the first company to register under Spain's new Royal Decree 903/2025 framework. This is a material regulatory milestone that opens a pharmaceutical-grade distribution pathway through hospital pharmacies in a major European market (50 million people), reinforcing the company's strategic position in regulated international cannabis markets and supporting its long-term growth in Europe.","company_name":"Curaleaf Holdings, Inc.","ticker":"CURLF","filing_date":"2026-07-14","form":"6-K","submitted_at":null,"items":[{"id":16407,"accession_number":"0001756770-26-000066","item_number":"EX-99.1","item_title":"a2026-07x13xcuraleafxfir.htm","event_type":"operational_other","event_domain":"operational","is_material":true,"confidence":0.85,"reasoning":"Curaleaf announced that Spain's AEMPS has approved registration of two standardized cannabis preparations (THC-dominant and CBD-dominant) developed by its Spanish subsidiary, making Curaleaf the first company to register under Spain's new Royal Decree 903/2025 framework. This is a material regulatory milestone that opens a pharmaceutical-grade distribution pathway through hospital pharmacies in a major European market (50 million people), reinforcing the company's strategic position in regulated international cannabis markets and supporting its long-term growth in Europe.","classifier_version":"claude-haiku-4-5-20251001+prompt-6be895f9","taxonomy_version":"v1.3","classified_at":"2026-07-14T14:33:44.069864+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":16407,"accession_number":"0001756770-26-000066","item_number":"EX-99.1","item_title":"a2026-07x13xcuraleafxfir.htm","event_type":"operational_other","event_domain":"operational","is_material":true,"confidence":0.85,"reasoning":"Curaleaf announced that Spain's AEMPS has approved registration of two standardized cannabis preparations (THC-dominant and CBD-dominant) developed by its Spanish subsidiary, making Curaleaf the first company to register under Spain's new Royal Decree 903/2025 framework. This is a material regulatory milestone that opens a pharmaceutical-grade distribution pathway through hospital pharmacies in a major European market (50 million people), reinforcing the company's strategic position in regulated international cannabis markets and supporting its long-term growth in Europe.","classifier_version":"claude-haiku-4-5-20251001+prompt-6be895f9","taxonomy_version":"v1.3","classified_at":"2026-07-14T14:33:44.069864+00:00","company_name":"Curaleaf Holdings, Inc.","ticker":"CURLF","filing_date":"2026-07-14"}]}